---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-056876"
form_type: "8-K"
ticker: "ACHV"
cik: "0000949858"
company_name: "ACHIEVE LIFE SCIENCES, INC."
filed_at: "2024-05-09T23:59:59+00:00"
generated_at: "2026-06-02T08:18:25.338037+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Achieve Life Sciences reports Q1 net loss of $6.5M; cash $66.4M; ORCA-OL trial starts May 2024

## Summary
- Cash, cash equivalents, restricted cash $66.4M as of March 31, 2024, after $60M upfront financing.
- Net loss for Q1 2024 was $6.5M; total operating expenses $6.0M.
- Feb 2024 financing raised $60M upfront with potential $64.2M from milestone-driven warrants.
- ORCA-OL long-term safety trial on track to initiate enrollment in May 2024; NDA submission expected H1 2025.
- Phase 2 ORCA-V1 vaping cessation results published in JAMA Internal Medicine.

## SEC filing metadata
- accession: 0000950170-24-056876
- form_type: 8-K
- ticker: ACHV
- cik: 0000949858
- company_name: ACHIEVE LIFE SCIENCES, INC.
- filed_at: 2024-05-09T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/949858/000095017024056876/0000950170-24-056876-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/949858/000095017024056876/achv-20240509.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-056876
- JSON: https://secwatch.observer/filing/0000950170-24-056876.json
- Plain text: https://secwatch.observer/filing/0000950170-24-056876.txt

## Key facts
- Earnings Releases
  ACHIEVE LIFE SCIENCES, INC. reported financial results for first quarter ended March 31, 2024.
  - Period: first quarter ended March 31, 2024
  - Result: reported results
  source text: On May 9, 2024, Achieve Life Sciences, Inc. issued a press release announcing its financial results for the first quarter ended March 31, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/949858/000095017024056876/0000950170-24-056876-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.